Skip to main content

epigenetics Archives

Sweatt, Tansey discuss influence of epigenetics on research

Nov. 2, 2017—Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks.

Read more

Reporter


Epigenetics expert Allis set for Sept. 7 Discovery Lecture

Aug. 31, 2017—Internationally known epigeneticist C. David Allis, Ph.D., will deliver the first Flexner Discovery Lecture of the academic year at 4 p.m. Thursday, Sept. 7, in room 208 Light Hall.

Read more

Reporter


Top cancer researchers reveal latest findings at VICC science retreat

May. 11, 2017—Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer.

Read more

Reporter


Esophageal cancer complexities

Mar. 16, 2017—New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers.

Read more

Health and Medicine Reporter Research


Saliva test for obesity risk

Jan. 24, 2017—“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.

Read more

Health and Medicine Reporter Research


Vanderbilt historian offers unsettling look at bioengineered near future

Dec. 1, 2015—Historian Michael Bess said that he found a whole new world of imminent advances in biotechnology that promise to transform society while he was researching 'Our Grandchildren Redesigned.'

Read more

myVU myVU News releases Research Society and Culture Trans-institutional Programs


Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Jan. 9, 2014—Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.

Read more

Health and Medicine Reporter Research


Dual-action enzyme protects esophagus

May. 9, 2013—An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus.

Read more

Health and Medicine Reporter Research


New drugs a good BET for brain cancer

Mar. 20, 2013—A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors.

Read more

Health and Medicine Reporter Research


Drugs reverse lung cancer cell changes

Feb. 1, 2012—Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.

Read more

Health and Medicine Reporter Research